
Glimisave M1 750 Tablet PR
Marketer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (1mg) + Metformin (750mg)
Overview Glimisave M1 750 Tablet PR
Diabetic patients may find relief with the anti-diabetic medication, Glimisave M1 750 Tablet PR, a dual-action formulation for adults with type 2 diabetes. This medication effectively manages blood glucose, requiring consistent daily intake at the same time, ideally with food. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use, even with controlled blood sugar, is crucial; abrupt cessation can lead to dangerously elevated glucose, potentially causing kidney complications, vision loss, neuropathy, and limb amputation. Remember, this drug is only one component of a comprehensive diabetes management plan; a balanced diet, regular exercise, and weight management, as recommended by your doctor, are equally vital. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms such as tremors, sweating, dizziness, and headaches; and always carry a fast-acting sugar source like glucose tablets or juice. Alcohol consumption heightens hypoglycemia risk and should be minimized. Other potential side effects include gastrointestinal upset (nausea, diarrhea, stomach pain), altered taste perception, headaches, upper respiratory infections, and weight gain. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Consult your doctor before using this medication if you are pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended under your physician's supervision.
Uses of Glimisave M1 750 Tablet PR
Managing Type 2 Diabetes
Major Benefits of Glimisave M1 750 Tablet PR:
Follow your physician's instructions or consult the product label for usage guidelines. Administer Glimisave M1 750 Tablet PR with a meal.
Common Side effects of Glimisave M1 750 Tablet PR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimisave M1 750 Tablet PR:
Follow your physician's instructions or consult the product information leaflet for dosage guidance. Administer Glimisave M1 750 Tablet PR with a meal.
How Glimisave M1 750 Tablet PR works:
Glimisave M1 750 Tablet PR combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose uptake, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimisave M1 750 Tablet PR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Glimisave M1 750 Tablet PR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingUNSAFE
Using Glimisave M1 750 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimisave M1 750 Tablet PR cautiously, potentially requiring dosage modification. Consult your physician for guidance. Glimisave M1 750 Tablet PR is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverCAUTION
Exercise caution when administering Glimisave M1 750 Tablet PR to individuals with hepatic impairment. Dosage modification of Glimisave M1 750 Tablet PR may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, Glimisave M1 750 Tablet PR is typically initiated at a reduced dosage; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Glimisave M1 750 Tablet PR :
Should you forget to take a Glimisave M1 750 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimisave M1 750 Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
